| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $256.9M | +8.5% |
| Cost of Revenue | $100.8M | +12.7% |
| Gross Profit | $156.0M | +6.0% |
| R&D Expense | $54.3M | +8.7% |
| SG&A Expense | $31.3M | +12.8% |
| Operating Income | -$6.9M | -73.5% |
| Pre-tax Income | -$6.1M | -118.3% |
| Income Tax | $760K | +138.4% |
| Net Income | -$6.9M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.9M | +1.9% |
| Accounts Receivable | $8.0M | -18.5% |
| Inventory | $13.1M | -33.9% |
| Current Assets | $56.2M | -11.8% |
| Total Assets | $149.2M | -6.3% |
| Current Liabilities | $51.7M | +0.4% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.6M | +116.8% |
| Capital Expenditures | $6.4M | +4.7% |
| Investing Cash Flow | -$6.4M | +81.8% |
| Financing Cash Flow | -$19.8M | -220.5% |
| Free Cash Flow | $20.2M | +229.7% |
| -726.5% |
| EPS (Basic) | -$0.26 | -766.7% |
| EPS (Diluted) | -$0.26 | -766.7% |
| Total Liabilities |
| $63.9M |
| -21.3% |
| Stockholders' Equity | $85.3M | +9.2% |